期刊文献+

缬沙坦对尼古丁所致大鼠血管内皮功能损伤的保护作用

The protective effect of valsartan on nicotine-induced endothelial dysfunction in rats
原文传递
导出
摘要 目的:探讨缬沙坦对尼古丁损伤大鼠肠系膜动脉内皮依赖性舒张(EDR)功能的保护作用及其机制。方法:将30只大鼠分为5组,即正常对照、尼古丁损伤组(2mg.kg-1,ip)、缬沙坦低、中、高剂量组(nicotine2mg.kg-1,ip+valsartan3,10,30mg.kg-1,ig),6周后检测各组肠系膜动脉环EDR及主动脉匀浆中一氧化氮(NO)、丙二醛(MDA)含量,一氧化氮合成酶(NOS)、超氧化物歧化酶(SOD)活性变化。结果:尼古丁使肠系膜动脉环EDR明显降低(54.03%),并伴随主动脉匀浆NO含量,NOS、SOD活性的下降及丙二醛含量的升高;而缬沙坦(中、高剂量组)使其EDR得到明显改善(73.06%,82.95%),并且抑制了尼古丁诱导的NO含量,NOS、SOD活性的下降及MDA的升高(P<0.05,与尼古丁损伤组比较)。结论:缬沙坦对尼古丁所致的血管损伤具有明显保护作用,该作用可能与其抗氧化,促进内皮细胞合成、释放NO有关。 OBJECTIVE To examine whether valsartan exerts beneficial effects on the nicotine-induced impairment of endo thelium-dependent relaxation (EDR) in rat mesenteric arteries and explore the possible mechanisms underlying the observed protective effects of valsartaru METHODS A total of 30 rats were randomly divided into 5 groups: control group, nicotine group(2 mg·kg^-1 ,ip), and 3 valsartan groups(3, 10 or 30 mg·kg^-1 , ig) consisting of 6 rats in each group. After 6 weeks, isometric tension recordings were used to assess EDR responses of mesenteric arteries. The NO, MDA contents and NOS, SOD activities in aorta homogenates were measured. RESULTS Administration of nicotine significantly inhibited EDR responses of mesenteric arteries (54. 03% ) and decreased the content of nitric oxide (NO) and nitric oxide synthase (NOS), superoxide dismutase (SOD) activities and increased the content of malondialdehyde (MDA) in aorta homogenates when compared with that of the control group. However, chronic valsartan treatment(middle, high dose) significantly improved the vasodilator response (73. 06, 82.95%) and prevented the reduction in nitrite/nitrate levels, the activity of NOS, SOD and the increase of MDA in the aorta homogenates. CONCLUSION Valsartan can be used to attenuate nicotine-induced endothelial dysfunction, an effect that may be related not only to antioxidation, but also to enhancing NO production by preventing the decrease in NOS.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第18期1550-1552,共3页 Chinese Journal of Hospital Pharmacy
关键词 缬沙坦 尼古丁 内皮依赖性舒张 valsartan nicotine endothelium-dependent relaxation
  • 相关文献

参考文献7

  • 1Ferrario CM, Richmond RS, Smith R. Renin-angiotensin system as a therapeutic target in managing atherosclerosis [J]. Am J Ther, 2004, 11(1): 44-53.
  • 2Luo HL, Zang WJ, Lu J, et al. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat[J]. Basic Clin Pharmacol Toxicol, 2006, 99(3): 237-245.
  • 3Cao YX, He LC, Xu CB, et al. Enhanced transcription of contractile 5-hydroxytryptamine 2A Receptors via extracellular signal-regulated kinase 1/2 after organ culture of rat mesenteric artery [J]. Basic Clin Pharmaeol Toxicol, 2005, 96 (4) : 282-288.
  • 4Biala G, Weglinska B. Blockade of the expression of mecamylamine precipitate nicotine withdrawal by calcium channel an tagonists[J]. Pharmacol Res, 2005, 51(5): 483-488.
  • 5Mayhan WG, Sharpe GM. Chronic exposure to nicotine alters endothelium-dependenl arteriolar dilatation: effect of superoxide dismutase[J]. J Appl Physio, 1999, 86(4): 1126-1134.
  • 6Cheng ZJ, Vaskonen T, Tikkanen I, el al. Endothelial Dysfunction and Sah-Sensitive Hypertension in Spontaneously Diabetic Goto-Kakizaki Rats [J ]. Hypertension, 2001, 37 (2): 433-439.
  • 7郑永红,白玉茹,胡锡衷,郑伟.小剂量联合应用缬沙坦和雷米普利对原发性高血压大鼠体内NO水平及心肌重塑的影响[J].中国全科医学,2007,10(3):211-214. 被引量:6

二级参考文献8

  • 1Domenic A Sica.Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy:its role in clinical practice[J].J Clin Hypertens,2003,5:414-420.
  • 2Domenic A Sica.Combination ACE inhibitor and angiotensin receptor blocker therapy-future considerations[J].J Clin Hypertens,2007,9:78-86.
  • 3Stergiou GS,Skeva II,Baibas NM,et al.Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension[J].J Cardiovasc Pharmacol,2000,35:937-941.
  • 4Weir MR,Weber MA,Neutel JM,et al.Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy:a clinical experience trial.ACTION Study Investigators[J].Am J Hypertens,2001,14:567-572.
  • 5Ke YS,Cao H,Yang T.Effect of combnation of valsartan with benazepril on blood pressure and 1eft ventricular hypertrophy in SHR[J].Acta Pharmacol Sin,2000,21:1043-1047.
  • 6Yagi S,Morita T,Katayama S.Combined treatment with an AT1 receptor blocker and angiotensin convertingenzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress[J].Hypertens Res,2004,27:129-35.
  • 7Levy BI.Can angiotensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease[J]? Circulation,2004,109:8-13.
  • 8党爱民,陈改玲,刘国仗.高血压的药物治疗进展[J].中国全科医学,2004,7(10):691-693. 被引量:19

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部